Some patients with diabetes may be missing critical safety alerts on their phones, the FDA warned on Wednesday.

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Jacek Olczak, Philip Morris International CEO, joins CNBC's 'Money Movers' to discuss the company's most recent earnings.

The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from ...

More than 5,900 bags of this Marketside Broccoli were sold. The states that are currently impacted by this recall are the ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

Broccoli florets Walmart stores in 20 states have been under a recall since late last year. The FDA now has updated its ...

If PH-ILD studies translate into the real world, the market opportunity for Liquidia is enormous. Where should we expect LQDA stock to be in the next few months? Find out.

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.